IHS Chemical Week

Regions :: North Asia :: Japan

Daiichi Sankyo to sell API plant at Akita to Japanese firm

7:25 AM MDT | August 8, 2014 | Deepti Ramesh

Pharmaceutical company Daiichi Sankyo (Tokyo) says that it has reached an agreement with finished dosage forms producer Alfresa Pharma (Osaka) to sell the active pharmaceutical ingredient (API) plant at Akita, Japan, owned by the Daiichi Sankyo Propharma (DSPP; Tokyo) subsidiary, to Alfresa. Financial details of the agreement have not been disclosed. The transaction is expected to be completed on 1 April 2015. Daiichi Sankyo is restructuring its pharma ingredient subsidiaries. The company decided in 2012 to reorganize three of its supply chain subsidiaries in...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa